Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors

被引：0
|
作者：
Huang, Xiu [1 ]
Russell, Meaghan K. [1 ]
Pantazi, Angeliki [2 ]
Lvova, Maria [1 ]
Vuzman, Dana [1 ]
Lyle, Stephen [3 ]
Tse, Julie Y. [4 ]
机构：
[1] KEW Inc, Cambridge, MA USA
[2] KEW Inc, Lethbridge, AB, Canada
[3] Univ Massachusetts, Worcester, MA 01605 USA
[4] KEW Inc, Tufts Med Ctr, Boston, MA USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1950
引用
收藏
页码：701 / 701
页数：1
相关论文
共 50 条
  • [11] Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
    Sanjeevani Arora
    Rodion Velichinskii
    Randy W. Lesh
    Usman Ali
    Michal Kubiak
    Pranshu Bansal
    Hossein Borghaei
    Martin J. Edelman
    Yanis Boumber
    Advances in Therapy, 2019, 36 : 2638 - 2678
  • [12] Imaging Biomarkers to Assess Response to Immune Checkpoint Inhibitors in Solid Tumors to Tailor Therapy COMMENT
    Summers, Ronald M.
    RADIOLOGY, 2021, 299 (01) : 120 - 121
  • [13] Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges
    Kyi, Chrisann
    Postow, Michael A.
    IMMUNOTHERAPY, 2016, 8 (07) : 821 - 837
  • [14] A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy
    Li, Siqi
    Tajiri, Kazuko
    INTERNAL MEDICINE, 2021, 60 (03) : 325 - 326
  • [15] Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: Clarity Amidst Rapid Evolution
    Dodd, Jonathan D.
    MacDermott, Roisin
    RADIOLOGY, 2020, 297 (01) : 97 - 98
  • [16] PREDICTORS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN METASTATIC SOLID TUMORS: REAL WORLD EVIDENCE
    Jacob, Aasems
    Wu, Jianrong
    Kolesar, Jill
    Durbin, Eric
    Mathew, Aju
    Arnold, Susanne
    Chauhan, Aman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A33 - A35
  • [17] Characterization of Encephalopathy Associated with Immune Checkpoint Inhibitor Therapy
    Wei, Danmeng
    Taraschenko, Olga
    NEUROLOGY, 2019, 92 (15)
  • [18] What's new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
    Tsang, Patricia C.
    Chen, Guoli
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) : 113 - 114
  • [19] Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
    Peyraud, Florent
    Italiano, Antoine
    CANCERS, 2020, 12 (06) : 1 - 28
  • [20] Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
    Zhao, Xianda
    Subramanian, Subbaya
    CANCER RESEARCH, 2017, 77 (04) : 817 - 822
12345